Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abigail M Wynne

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Basic Research in Cardiology|May 29, 2007
Ischemic preconditioning targets the reperfusion phaseDerek J Hausenloy, Abigail M Wynne, Derek M Yellon
Journal of Cardiovascular Pharmacology|November 25, 2005
Pioglitazone mimics preconditioning in the isolated perfused rat heart: a role for the prosurvival kinases PI3K and P42/44MAPKAbigail M Wynne, Mihaela M Mocanu, Derek M Yellon
Journal of Cellular and Molecular Medicine|June 11, 2009
Preconditioning the diabetic human myocardiumVivek Sivaraman, Derek J Hausenloy, Abigail M Wynne, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 25, 2012
Glimepiride treatment facilitates ischemic preconditioning in the diabetic heartDerek J Hausenloy, Abigail M Wynne, Mihaela M Mocanu, et al.
Journal of Cardiovascular Pharmacology|April 25, 2009
The cardioprotective actions of leptin are lost in the Zucker obese (fa/fa) ratRichard A Dixon, Sean M Davidson, Abigail M Wynne, et al.
Basic Research in Cardiology|August 19, 2007
Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injuryJames C Simpkin, Derek M Yellon, Sean M Davidson, et al.
Cardiovascular Diabetology|October 24, 2013
Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent mannerDerek J Hausenloy, Hannah J Whittington, Abigail M Wynne, et al.
Basic Research in Cardiology|December 15, 2007
Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore openingGurpreet S Bhamra, Derek J Hausenloy, Sean M Davidson, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 25, 2010
Failure of the adipocytokine, resistin, to protect the heart from ischemia-reperfusion injuryChristopher C T Smith, Shiang Y Lim, Abigail M Wynne, et al.
Cardiovascular Drugs and Therapy|October 10, 2007
Temporal changes in myocardial salvage kinases during reperfusion following ischemia: studies involving the cardioprotective adipocytokine apelinChristopher C T Smith, Michaela M Mocanu, Jonathan Bowen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Basic Research in Cardiology|May 29, 2007
Ischemic preconditioning targets the reperfusion phaseDerek J Hausenloy, Abigail M Wynne, Derek M Yellon
Journal of Cardiovascular Pharmacology|November 25, 2005
Pioglitazone mimics preconditioning in the isolated perfused rat heart: a role for the prosurvival kinases PI3K and P42/44MAPKAbigail M Wynne, Mihaela M Mocanu, Derek M Yellon
Journal of Cellular and Molecular Medicine|June 11, 2009
Preconditioning the diabetic human myocardiumVivek Sivaraman, Derek J Hausenloy, Abigail M Wynne, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 25, 2012
Glimepiride treatment facilitates ischemic preconditioning in the diabetic heartDerek J Hausenloy, Abigail M Wynne, Mihaela M Mocanu, et al.
Journal of Cardiovascular Pharmacology|April 25, 2009
The cardioprotective actions of leptin are lost in the Zucker obese (fa/fa) ratRichard A Dixon, Sean M Davidson, Abigail M Wynne, et al.
Basic Research in Cardiology|August 19, 2007
Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injuryJames C Simpkin, Derek M Yellon, Sean M Davidson, et al.
Cardiovascular Diabetology|October 24, 2013
Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent mannerDerek J Hausenloy, Hannah J Whittington, Abigail M Wynne, et al.
Basic Research in Cardiology|December 15, 2007
Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore openingGurpreet S Bhamra, Derek J Hausenloy, Sean M Davidson, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 25, 2010
Failure of the adipocytokine, resistin, to protect the heart from ischemia-reperfusion injuryChristopher C T Smith, Shiang Y Lim, Abigail M Wynne, et al.
Cardiovascular Drugs and Therapy|October 10, 2007
Temporal changes in myocardial salvage kinases during reperfusion following ischemia: studies involving the cardioprotective adipocytokine apelinChristopher C T Smith, Michaela M Mocanu, Jonathan Bowen, et al.
Pageof 2